This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Fusion Antibodies Limited. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Hugh Morgan - Innovator in Antibody Technology
Introduction
Hugh Morgan is a notable inventor based in Belfast Antrim, GB. He has made significant contributions to the field of biotechnology, particularly in the development of antibody libraries. His innovative work has the potential to enhance the efficiency of antibody binding and affinity maturation.
Latest Patents
Hugh Morgan holds a patent for an "Antibody library and method." This patent relates to methods of generating antibody libraries, which are crucial for improving antibody binding through affinity maturation assays. The invention involves identifying specific motifs in the nucleotide sequence of target antibodies that can be recognized by deamination somatic hypermutation enzymes. By creating a small library of variants incorporating these mutations, a higher proportion of variants with increased affinity can be produced. The technique has been demonstrated on trastuzumab and Cathepsin S antibodies, showcasing its effectiveness.
Career Highlights
Hugh Morgan is associated with Fusion Antibodies Limited, where he applies his expertise in antibody technology. His work has contributed to advancements in the field, particularly in the generation of antibody libraries that can significantly improve therapeutic outcomes.
Collaborations
Hugh Morgan has collaborated with notable colleagues, including Richard John Buick and Christopher Scott. These collaborations have further enriched his research and development efforts in antibody technology.
Conclusion
Hugh Morgan's innovative work in antibody libraries represents a significant advancement in biotechnology. His contributions have the potential to transform the landscape of antibody development and improve therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile